These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 28521288)
21. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway. Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973 [TBL] [Abstract][Full Text] [Related]
22. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin. Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950 [TBL] [Abstract][Full Text] [Related]
23. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187 [TBL] [Abstract][Full Text] [Related]
24. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer. Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036 [TBL] [Abstract][Full Text] [Related]
25. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
27. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858 [TBL] [Abstract][Full Text] [Related]
28. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078 [TBL] [Abstract][Full Text] [Related]
29. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869 [TBL] [Abstract][Full Text] [Related]
30. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways. Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis. Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092 [TBL] [Abstract][Full Text] [Related]
32. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer. Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118 [TBL] [Abstract][Full Text] [Related]
35. Pattern of LRP6 gene expression in tumoral tissues of colorectal cancer. Rismani E; Fazeli MS; Mahmoodzadeh H; Movassagh A; Azami S; Karimipoor M; Teimoori-Toolabi L Cancer Biomark; 2017; 19(2):151-159. PubMed ID: 28387660 [TBL] [Abstract][Full Text] [Related]
36. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy. Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879 [TBL] [Abstract][Full Text] [Related]
37. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism. Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609 [TBL] [Abstract][Full Text] [Related]
38. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769 [TBL] [Abstract][Full Text] [Related]
39. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling. Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734 [TBL] [Abstract][Full Text] [Related]
40. Activation of the clock gene TIMELESS by H3k27 acetylation promotes colorectal cancer tumorigenesis by binding to Myosin-9. Cao M; Wang Y; Xiao Y; Zheng D; Zhi C; Xia X; Yuan X J Exp Clin Cancer Res; 2021 May; 40(1):162. PubMed ID: 33971927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]